(85 days)
No
The device description and performance studies focus on the material properties and mechanical performance of a biological implant, with no mention of AI or ML.
No.
A therapeutic device is one that treats a disease or condition. This device is intended for "reinforcement of soft tissue where weakness exists" and acts as a "resorbable scaffold which initially has sufficient mechanical strength to assist with a soft tissue repair, but then resorbs and is replaced by the patients own tissue," which indicates support and repair, not treatment of a disease.
No
The device is an implant intended to reinforce soft tissue, acting as a resorbable scaffold that is replaced by the patient's own tissue. It is not described as detecting, diagnosing, or monitoring a disease or condition.
No
The device description clearly states it is a physical implant made from biological material (porcine small intestine submucosa) and describes its mechanical properties and biocompatibility, indicating it is a hardware device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "reinforcement of soft tissue where weakness exists" in "general surgical procedures." This describes a device used in vivo (within the body) during surgery.
- Device Description: The description details a physical implant made from biological material (porcine small intestine submucosa) intended to be surgically placed and integrated into the patient's tissue.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens in vitro (outside the body), such as blood, urine, or tissue samples, to provide information about a patient's health status, diagnosis, or treatment.
IVD devices are used to perform tests on samples taken from the body, while this device is a surgical implant used directly on the patient's tissue.
N/A
Intended Use / Indications for Use
The Restore Orthobiologic Soft Tissue Implant is intended for use in general surgical procedures for reinforcement of soft tissue where weakness exists. The device is intended to act as a resorbable scaffold which initially has sufficient mechanical strength to assist with a soft tissue repair, but then resorbs and is replaced by the patients own tissue.
Product codes
79 FTM
Device Description
The Restore Orthibiologic Soft Tissue Implant is a round device, manufactured from 10 plys of Small Intestine Submucosa, (SIS). SIS is a bionaterial desived from porcine small intestine. SIS is composed presionshately of water and collagen. This material to the material approved in IDF. G960196 for investigational use as an Anterior Cruciate Ligament (ACL) replacement device and submitted in K974540 for Hernia Repair.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Mechanical testing shows that the Restore Orthobiologic Soft Tissue Implant and the BioVascular Supple Periguard have comparable suture retention strength and mechanical strength as measured by ball butst tests. Biocompatibility tests, performed according to ISO 10993, other accepted standards and other appropriate test methods indicate that the SIS material is biocompatible. Numerous animal efficacy studies indicate that SIS, in various configurations is efficacious when used for soft tissue repair or soft tise ue replacement. These studies include: repair of abdominal aponeuroses and the abdominal wall, fascial and capsular defects, and patellar and achilles tendons, and replacement of infraspinatus tendras and cranial cruciate ligaments. In all of these studies the SIS implant served as a scaffold for hew tissue formation and no evidence of rejection of the material was observed.
Key Metrics
Not Found
Predicate Device(s)
K970561, K974540, K923657, K973170, K980431
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.
0
SEP 2 5 1998
CLINREGLGL
SUMMARY OF SAFETY AND EFFECTIVENESS
| NAME OF SPONSOR: | DePuy, Inc. P.O. Box 988 Warsaw, Indiana 46581-0988 |
|---|---|
| 510(k) CONTACT: | Cheryl Hastings Manager, Regulatory Submissions |
| TRADE NAME: | DePuy OrthoTech Restore Orthobiologic Soft Tissue Implant |
| COMMON NAME: | Surgical Mesh |
| CLASSIFICATION: | 878.3300 - Surgical Mesh |
| DEVICE PRODUCT CODE: | 79 FTM |
| SUBSTANTIALLY EQUIVALENT DEVICES: |
- · Organogenesis Graft Patch (K970561)
- · Sentron SIS Hernia Repair Device (K974540)
- · Bio-Vascular Supple Peri-guard (K923657)
- · Cook Biotech Inc. SIS Wound Dressing (K973170)
- · Cook Biotech Inc. SIS Surgical Mesh (K980431)
DEVICE DESCRIPTION AND INTENDED USE:
The Restore Orthibiologic Soft Tissue Implant is a round device, manufactured from 10 plys of Small Intestine Submucosa, (SIS). SIS is a bionaterial desived from porcine small intestine. SIS is composed presionshately of water and collagen. This material to the material approved in IDF. G960196 for investigational use as an Anterior Cruciate Ligament (ACL) replacement device and submitted in K974540 for Hernia Repair.
The Restore Orthobiologic Soft Tissue Implant is intended for use in general surgical procedures for reinforcement of soft tissue where weakness exists. The device is intended to act as a resorbable scaffold which initially has sufficient mechanical strength to assist with a soft tissue repair, but then resorbs and is replaced by the patients own tissue.
BASIS OF SUBSTANTIAL EQUIVALENCE:
The DePuy Orth Tech Restore Orthobiologic Soft Tissue Implant is substantially equivalent to the above listed devices in that it is manufactured from the same matcrial (SIS. porcine small intessine submucosa) as the Sentron SIS Hernia Repair Device and the Cook Biotech Inc. SIS Wound Dressing and SIS Surgical Mesh. The material is very similar to that of the Organogenesis Graft Patch (described as cross-linked porcine collagen). It has the same intended use (reinforcing soft tissue) as the Organogenesis Graft Patch, the Bio-Vascular Supple Peri-guard, and the SIS Surgical Mesh and it has : similar design to all five of these soft tissue patches. Mechanical testing shows that the Restore Orthobiologic Soft Tissue Implant and the BioVascular Supple Periguard have comparable suture retention strength and mechanical strength as measured by ball butst tests. Biocompatibility tests, performed according to ISO 10993, other accepted standards and other appropriate test methods indicate that the SIS material is biocompatible. Numerous animal efficacy studies indicate that SIS, in various configurations is efficacious when used for soft tissue repair or soft tise ue replacement. These studies include: repair of abdominal aponeuroses and the
1
abdominal wall, fascial and capsular defects, and patellar and achilles tendons, and replacement of infraspinatus tendras and cranial cruciate ligaments. In all of these studies the SIS implant served as a scaffold for hew tissue formation and no evidence of rejection of the material was observed.
2
Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like figure with three curved lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird-like figure. The text is in all capital letters and is evenly spaced around the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 2 5 1998
Ms. Cheryl K. Hastings Manager, Requlatory Submission Depuy, Inc. 700 Orthopaedic Drive Warsaw, Indiana 46581-0988
Re: K982330 Trade Name: DePuy OrthoTech Restore Orthobiologic Soft Tissue Implant Requlatory Class: II Product Code: FTM June 30, 1998 Dated: Received: July 02, 1998
Dear Ms. Hastings:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the qeneral controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Ms. Cheryl K. Hastings
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Col. Mr. Histo. Bio. Res. M.
a M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known)
Device Name DePuy OrthoTech Restore Orthobiologic Soft Tissue Implant
Indications for Use:
:
The DePuy OrthoTech Restore Orthobiologic Soft Tissue Implant is intended for use in general surgical procedures for reinforcement of soft tissue where weakness exists.
Concurrence of CDRH, Office of Device Evaluation
ision Sign-Off)
(Division Sign-Off)
Division of General Restorative Devices K982330
510(k) Number
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use_
. . .